Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.

Axel Heidenreich; Peter Albers; Johannes Classen; Markus Graefen; Jürgen Gschwend; Jörg Kotzerke; Susanne Krege; Jens Lehmann; Rohde Detlef; Heinz Schmidberger; Michael Uder; Hajo Zeeb

Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.

Standard

Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society. / Heidenreich, Axel; Albers, Peter; Classen, Johannes; Graefen, Markus; Gschwend, Jürgen; Kotzerke, Jörg; Krege, Susanne; Lehmann, Jens; Detlef, Rohde; Schmidberger, Heinz; Uder, Michael; Zeeb, Hajo.

In: UROL INT, Vol. 85, No. 1, 1, 2010, p. 1-10.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Heidenreich, A, Albers, P, Classen, J, Graefen, M, Gschwend, J, Kotzerke, J, Krege, S, Lehmann, J, Detlef, R, Schmidberger, H, Uder, M & Zeeb, H 2010, 'Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.', UROL INT, vol. 85, no. 1, 1, pp. 1-10. <http://www.ncbi.nlm.nih.gov/pubmed/20693823?dopt=Citation>

APA

Heidenreich, A., Albers, P., Classen, J., Graefen, M., Gschwend, J., Kotzerke, J., Krege, S., Lehmann, J., Detlef, R., Schmidberger, H., Uder, M., & Zeeb, H. (2010). Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society. UROL INT, 85(1), 1-10. [1]. http://www.ncbi.nlm.nih.gov/pubmed/20693823?dopt=Citation

Vancouver

Heidenreich A, Albers P, Classen J, Graefen M, Gschwend J, Kotzerke J et al. Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society. UROL INT. 2010;85(1):1-10. 1.

Bibtex

@article{c6740888e6d04e8eadc284700bd59abf,

title = "Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.",

abstract = "Imaging studies are an integral and important diagnostic modality to stage, to monitor and follow-up patients with metastatic urogenital cancer. The currently available guidelines on diagnosis and treatment of urogenital cancer do not provide the clinician with evidence-based recommendations for daily practice.",

author = "Axel Heidenreich and Peter Albers and Johannes Classen and Markus Graefen and J{\"u}rgen Gschwend and J{\"o}rg Kotzerke and Susanne Krege and Jens Lehmann and Rohde Detlef and Heinz Schmidberger and Michael Uder and Hajo Zeeb",

year = "2010",

language = "Deutsch",

volume = "85",

pages = "1--10",

journal = "UROL INT",

issn = "0042-1138",

publisher = "S. Karger AG",

number = "1",

}

RIS

TY - JOUR

T1 - Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.

AU - Heidenreich, Axel

AU - Albers, Peter

AU - Classen, Johannes

AU - Graefen, Markus

AU - Gschwend, Jürgen

AU - Kotzerke, Jörg

AU - Krege, Susanne

AU - Lehmann, Jens

AU - Detlef, Rohde

AU - Schmidberger, Heinz

AU - Uder, Michael

AU - Zeeb, Hajo

PY - 2010

Y1 - 2010

N2 - Imaging studies are an integral and important diagnostic modality to stage, to monitor and follow-up patients with metastatic urogenital cancer. The currently available guidelines on diagnosis and treatment of urogenital cancer do not provide the clinician with evidence-based recommendations for daily practice.

AB - Imaging studies are an integral and important diagnostic modality to stage, to monitor and follow-up patients with metastatic urogenital cancer. The currently available guidelines on diagnosis and treatment of urogenital cancer do not provide the clinician with evidence-based recommendations for daily practice.

M3 - SCORING: Zeitschriftenaufsatz

VL - 85

SP - 1

EP - 10

JO - UROL INT

JF - UROL INT

SN - 0042-1138

IS - 1

M1 - 1

ER -